Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RARE
RARE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RARE News
Krensavage Increases Stake in Ultragenyx Pharmaceutical
12h ago
Fool
Krensavage Increases Stake in Ultragenyx Pharmaceutical
12h ago
NASDAQ.COM
Ultragenyx Grants Restricted Stock Units to New Executives
May 22 2026
Newsfilter
Emerging Trends in Rare Disease Research
May 07 2026
Newsfilter
Emerging Trends in Rare Disease Drug Development
May 07 2026
CNBC
Ultragenyx Pharmaceutical Q1 2026 Earnings Call Insights
May 06 2026
seekingalpha
Ultragenyx Pharmaceutical Q1 Earnings Miss Expectations
May 05 2026
seekingalpha
Ultragenyx Grants Restricted Stock Units to New Executives
Apr 24 2026
Newsfilter
A Doctor's Journey with His Son's Rare Disease
Apr 09 2026
CNBC
Ultragenyx Faces Class Action Lawsuit Over Stock Losses
Apr 06 2026
Globenewswire
Class Action Lawsuit Reminder Against Ultragenyx Pharmaceutical Inc.
Apr 06 2026
Globenewswire
Ultragenyx Pharmaceutical Class Action Notice
Apr 05 2026
Globenewswire
Class Action Lawsuit Filed Against Ultragenyx Pharmaceutical Inc.
Apr 05 2026
Globenewswire
Ultragenyx Pharmaceutical Class Action Reminder
Apr 04 2026
PRnewswire
Faruqi & Faruqi Encourages Ultragenyx Investors to Reach Out
Apr 04 2026
PRnewswire
Ultragenyx Pharmaceutical Faces Class Action Lawsuit
Apr 03 2026
PRnewswire
Show More News
